Inovio Pharmaceuticals Inc vs Remitly Global Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Remitly Global Inc trades at $23.73 (market cap $4.97B). The key difference: Remitly Global Inc is far larger — about 63.3× Inovio Pharmaceuticals Inc's market cap, and Remitly Global Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | RELY | |
|---|---|---|
Market Cap | $78.55M | $4.97B |
Sector | Health | Technology |
52-Week High | $2.87 | $25.93 |
52-Week Low | $0.66 | $12.20 |
Enterprise Value | $49.56M | $4.33B |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →